Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.230
-0.130 (-3.87%)
Jul 24, 2025, 11:51 AM - Market open

Rocket Pharmaceuticals Stock Forecast

RCKT's stock price has decreased by -86.83% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 13 analysts that cover Rocket Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $16.54, which forecasts a 412.07% increase in the stock price over the next year. The lowest target is $2.5 and the highest is $44.

Price Target: $16.54 (+412.07%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$2.50$16.54$13$44
Change-22.60%+412.07%+302.48%+1262.2%
* Price targets were last updated on Jun 17, 2025.

Analyst Ratings

The average analyst rating for Rocket Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy544344
Buy455555
Hold111444
Sell000000
Strong Sell000000
Total101010121313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Needham
Needham
Hold
Maintains
n/a
HoldMaintainsn/an/aJul 24, 2025
UBS
UBS
Strong Buy
Maintains
$12$5
Strong BuyMaintains$12$5+54.80%Jun 17, 2025
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$34$11
Strong BuyMaintains$34$11+240.56%Jun 3, 2025
B of A Securities
B of A Securities
Strong Buy
Maintains
$32$9
Strong BuyMaintains$32$9+178.64%May 28, 2025
BMO Capital
BMO Capital
Buy
Maintains
$30$8
BuyMaintains$30$8+147.68%May 28, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 249.83M
Revenue Next Year
n/a
EPS This Year
-2.26
from -2.73
EPS Next Year
-1.81
from -2.26
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028FY 2029
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028Dec 31, 2029
Revenue
12.10M85.79M137.13M144.89M249.83M
Revenue Growth
-608.87%59.85%5.66%72.43%---
EPS
-2.52-2.67-3.26-2.92-2.73-2.26-1.81-1.16
EPS Growth
--------
Forward PE
--------
No. Analysts
-----201914
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High150.2M321.3M581.7M
Avg12.1M85.8M137.1M
Lown/an/an/a

Revenue Growth

Revenue Growth20252026202720282029
High
-39.9%
2,554.5%
578.1%
Avg
-95.2%
608.9%
59.8%
Low---

EPS Forecast

EPS20252026202720282029
High-2.11-1.041.85
Avg-2.26-1.81-1.16
Low-2.53-2.36-1.94

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.